Emerging roles of JMJD3 in cancer
- PMID: 35239138
- DOI: 10.1007/s12094-021-02773-9
Emerging roles of JMJD3 in cancer
Erratum in
-
Correction to: Emerging roles of JMJD3 in cancer.Clin Transl Oncol. 2022 Oct;24(10):2044. doi: 10.1007/s12094-022-02871-2. Clin Transl Oncol. 2022. PMID: 35789470 No abstract available.
Abstract
Histone lysine methylation plays a key role in gene activation and repression. The trimethylation of histone H3 on lysine-27 (H3K27me3) is a critical epigenetic event that is controlled by Jumonji domain-containing protein-3 (JMJD3). JMJD3 is a histone demethylase that specifically removes methyl groups. Previous studies have suggested that JMJD3 has a dual role in cancer cells. JMJD3 stimulates the expression of proliferative-related genes and increases tumor cell growth, propagation, and migration in various cancers, including neural, prostate, ovary, skin, esophagus, leukemia, hepatic, head and neck, renal, lymphoma, and lung. In contrast, JMJD3 can suppress the propagation of tumor cells, and enhance their apoptosis in colorectal, breast, and pancreatic cancers. In this review, we summarized the recent advances of JMJD3 function in cancer cells.
Keywords: Cancer; Epigenome; Invasion; JMJD3; Metastasis.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. - DOI
-
- Ellender G, Coveney J. Flavor alterations in cancer treatment: extrinsic factors as a means of augmentation. Clin Nutr ESPEN. 2021;43:76–89. - PubMed
-
- Plutynski A. Is cancer a matter of luck? Biol Philos. 2021;36:1–28.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical